MISSO, Gabriella
 Distribuzione geografica
Continente #
EU - Europa 1.603
NA - Nord America 1.584
AS - Asia 364
AF - Africa 4
OC - Oceania 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.562
Nazione #
US - Stati Uniti d'America 1.580
IE - Irlanda 554
IT - Italia 319
GB - Regno Unito 184
UA - Ucraina 182
DE - Germania 146
CN - Cina 104
SG - Singapore 78
VN - Vietnam 72
FI - Finlandia 65
GR - Grecia 54
TR - Turchia 43
FR - Francia 34
SE - Svezia 28
PK - Pakistan 19
KR - Corea 18
BE - Belgio 14
CZ - Repubblica Ceca 11
IR - Iran 9
IN - India 8
CA - Canada 4
JP - Giappone 4
TW - Taiwan 4
AT - Austria 3
AU - Australia 3
BR - Brasile 3
HK - Hong Kong 3
NL - Olanda 3
SC - Seychelles 3
RU - Federazione Russa 2
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
ID - Indonesia 1
KE - Kenya 1
MD - Moldavia 1
QA - Qatar 1
SI - Slovenia 1
Totale 3.562
Città #
Dublin 554
Chandler 308
Jacksonville 300
Ann Arbor 81
New York 73
Dong Ket 72
Ashburn 69
Princeton 69
Medford 61
Bremen 60
Roxbury 53
Beijing 52
Boardman 51
Singapore 44
Caserta 42
Woodbridge 36
Naples 34
Wilmington 29
Aversa 28
Des Moines 24
San Mateo 20
Napoli 19
Mountain View 15
Seoul 15
Brussels 14
Helsinki 13
Brno 11
Cambridge 11
San Nicola la Strada 10
Rome 9
Falls Church 8
Milan 8
Bahawalpur 7
Cava Dei Tirreni 7
Munich 7
Düsseldorf 6
Zhengzhou 6
Auburn Hills 5
Avellino 5
Houston 5
Nanjing 5
Gunzenhausen 4
Lappeenranta 4
London 4
Los Angeles 4
Taipei 4
Bascape 3
Castellammare Di Stabia 3
Jinan 3
Norwalk 3
Nottingham 3
San Giorgio a Cremano 3
Santa Clara 3
Saviano 3
Tianjin 3
Vienna 3
Washington 3
Capri 2
Castel Volturno 2
Colleferro 2
Forino 2
Groningen 2
Guangzhou 2
Haikou 2
Hebei 2
Hefei 2
Hong Kong 2
Istanbul 2
Latina 2
Melbourne 2
Prata 2
Pune 2
Redwood City 2
San Felice A Cancello 2
Seattle 2
Shanghai 2
Shenyang 2
Tricase 2
Vellore 2
Aigaleo 1
Bolzano 1
Caiazzo 1
Campania 1
Campobasso 1
Campodarsego 1
Capua 1
Catania 1
Cava de' Tirreni 1
Centro 1
Changsha 1
Clifton 1
Clifton Park 1
Copenhagen 1
Doha 1
Edinburgh 1
Elora 1
Fairfield 1
Ferrara 1
Florence 1
Forest City 1
Totale 2.364
Nome #
Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer. 90
W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac 82
A miRNA signature suggestive of nodal metastases from laryngeal carcinoma. 82
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 77
"Phase II trial of bevacizumab and dose/dense chemoterapy with cisplatin and metronomic daily oral etoposide in advanced non small cell lung cancer patients" 74
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 71
Mitochondria as playmakers of apoptosis, autophagy and senescence 71
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 70
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 65
Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid. 65
Gene interference strategies as a new tool for the treatment of prostate cancer 64
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 63
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma 62
Definition of microRNAs predictive of nodal involvement in laringeal cancer patients 60
Cytotoxic drugs up-regulate Epidermal Growth Factor Receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted Antibody-Dependent-Cell-mediated-Cytotoxicity (ADCC) 59
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action 59
Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey. 58
Possible roles of transglutaminases in molecular mechanisms responsible for cancer and human neurodegenerative diseases. 58
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 58
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 56
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 56
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. 55
Emerging pathways as individualized therapeutic target of multiple myeloma. 55
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. 54
Early detection of laryngeal cancer: prominence of miRNA signature as a new tool for clinicians 54
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 54
Definition of miRNA Signatures of Nodal Metastasis in LCa: miR-449a Targets Notch Genes and Suppresses Cell Migration and Invasion 54
Possible antioxidant role of SPA therapy with chlorine-sulphur-bicarbonate mineral water. 53
Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports 53
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. 52
Measurement of autophagy by flow cytometry 52
Optimal Management of Prostate Cancer Based on its Natural Clinical History 52
MOLECULAR TARGETS FOR THE TREATMENT OF MULTIPLE MYELOMA 51
Bisphosphonates and cancer: what opportunities from nanotechnology? 51
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 51
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin 49
Tumour-specific uptake of anti-cancer drugs: the future is here. 49
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 48
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 48
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: The GOLFIG-2 multicentric open-label randomized phase III trial 47
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 47
Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis). 46
Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients. 46
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 46
Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice 46
Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells. 45
MicroRNAs’ Crucial Role in Salivary Gland Cancers’ Onset and Prognosis 45
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 44
Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment 43
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 43
Poorly differentiated neuroendocrine larynx carcinoma: Clinical features and mirnas signature—a new goal for early diagnosis and therapy? 43
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma. 42
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems 42
Mir-34: a new weapon against cancer? 41
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 41
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 41
Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC. 39
Role of perineural invasion as a prognostic factor in laryngeal cancer 38
Lipid Nanoparticles to Deliver miRNA in Cancer 37
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 37
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines 37
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 35
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 35
Hepatocarcinoma: genetic and epigenetic features 34
Non-coding RNAs as a new dawn in tumor diagnosis 34
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research 32
Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies. 30
The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response 30
Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma 30
MICRO-RNAs as biological markers for prevention and diagnosis of oral carcinomas 30
Prognostic patterns for predicting lymph node metastasis in patients with squamous cell carcinoma of the larynx 28
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 22
MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer 21
microRNA Detection via Nanostructured Biochips for Early Cancer Diagnostics 19
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(Iii) complex with superior anticancer bioactivity 19
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics 18
Immune cell infiltration and inflammatory landscape in primary brain tumours 17
Biosensore per rivelazione di firma molecolare di miRNA ad interesse diagnostico in patologie umane 16
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review 13
Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection 12
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma 12
Nanoparticelle e loro usi 12
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 11
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer 9
Aminobisphosphonates and nano technologically-modified aminobisphosphonates: A new dawn in the treatment of bone and extra-bone tumors? 4
Totale 3.794
Categoria #
all - tutte 15.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020343 0 60 8 13 63 11 77 22 26 21 29 13
2020/2021525 39 6 57 27 60 13 64 47 29 42 61 80
2021/2022444 23 12 1 7 147 11 6 14 18 25 43 137
2022/20231.138 125 19 18 118 104 121 4 63 506 19 23 18
2023/2024645 35 15 90 29 148 82 7 23 37 9 46 124
2024/202555 27 28 0 0 0 0 0 0 0 0 0 0
Totale 3.794